Epidemiological and genomic surveillance of influenza virus A, RSV B and SARS-CoV-2 in Bangladesh (2022-2024) - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Epidemiological and genomic surveillance of influenza virus A, RSV B, and SARS-CoV-2 in Bangladesh, 2022-2024

  • By

  • Mohammad Jubair

  • Mst. Noorjahan Begum

  • Nure Sharaf Nower Samia

  • Md. Shaheen Alam

  • Yeasir Karim

  • Tazkia Ahmed

  • Eleonora Cella

  • Saikt Rahman

  • Mohammad Tanbir Habib

  • Manjur H. Khan

  • Tahmina Shirin

  • Fahmida Chowdhury

  • Firdausi Qadri

  • Mustafizur Rahman

  • July 18, 2026

Share

  • 1

    The NRPGS consortium in Bangladesh was established in 2022 to enhance genomic surveillance of respiratory pathogens including influenza, RSV, and SARS-CoV-2.

  • 2

    Nine sentinel hospitals were selected for the NRPGS to ensure nationwide representation and high patient turnover for respiratory pathogen monitoring.

  • 3

    Respiratory specimens were collected from patients meeting WHO criteria for severe acute respiratory infection or influenza-like illness from October 2022 through March 2024.

  • 4

    SARS-CoV-2, influenza A, and RSV B were prioritized for sequencing, with a focus on RSV B due to its prevalence in severe pediatric cases.

  • 5

    The study utilized advanced sequencing technologies, including Oxford Nanopore and Illumina platforms, to generate high-quality genomic data for public health use.

Original Source(s)

Epidemiological and genomic surveillance of influenza virus A, RSV B and SARS-CoV-2 in Bangladesh (2022-2024)

  • by Mohammad Jubair, Mst. Noorjahan Begum, Nure Sharaf Nower Samia, Md. Shaheen Alam, Yeasir Karim, Tazkia Ahmed, Eleonora Cella, Saikt Rahman, Mohammad Tanbir Habib, Manjur H. Khan, Tahmina Shirin, Fahmida Chowdhury, Firdausi Qadri, Mustafizur Rahman

  • July 18, 2026

Related Content

The regulatory mechanisms and translational applications of non-coding RNA in SARS-CoV-2 infection-related cardiovascular pathology

Editorial: New discoveries and challenges in pediatric infectious diseases: epidemiological, clinical, and pathogenic advances

How Pandemics Have Reshaped the Respiratory Virus Data Landscape in Europe: Scoping Review